These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 24177197)

  • 41. A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer.
    Laxman B; Morris DS; Yu J; Siddiqui J; Cao J; Mehra R; Lonigro RJ; Tsodikov A; Wei JT; Tomlins SA; Chinnaiyan AM
    Cancer Res; 2008 Feb; 68(3):645-9. PubMed ID: 18245462
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-up.
    Johnson H; Guo J; Zhang X; Zhang H; Simoulis A; Wu AHB; Xia T; Li F; Tan W; Johnson A; Dizeyi N; Abrahamsson PA; Kenner L; Feng X; Zou C; Xiao K; Persson JL; Chen L
    BMC Med; 2020 Dec; 18(1):376. PubMed ID: 33256740
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assays for prostate cancer : changing the screening paradigm?
    Hansen J; Rink M; Graefen M; Shariat S; Chun FK
    Mol Diagn Ther; 2013 Feb; 17(1):1-8. PubMed ID: 23355098
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimizing prostate cancer screening; prospective randomized controlled study of the role of PSA and PCA3 testing in a sequential manner in an opportunistic screening program.
    Rubio-Briones J; Casanova J; Dumont R; Rubio L; Fernandez-Serra A; Casanova-Salas I; Domínguez-Escrig J; Ramírez-Backhaus M; Collado A; Gómez-Ferrer A; Iborra I; Monrós JL; Ricós JV; Solsona E; Salas D; Martínez F; Lopez-Guerrero JA
    Actas Urol Esp; 2014 May; 38(4):217-23. PubMed ID: 24169211
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current biomarkers for diagnosing of prostate cancer.
    Stephan C; Jung K; Ralla B
    Future Oncol; 2015; 11(20):2743-55. PubMed ID: 26358139
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New Molecular Markers for Prostate Cancer Diagnosis.
    Amiri M; Asadi Samani L; Kashi AH; Khadem N; Ziaee SAM; Mowla SJ
    Urol J; 2024 Feb; 21(1):1-13. PubMed ID: 37818554
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rational basis for the combination of PCA3 and TMPRSS2:ERG gene fusion for prostate cancer diagnosis.
    Robert G; Jannink S; Smit F; Aalders T; Hessels D; Cremers R; Mulders PF; Schalken JA
    Prostate; 2013 Jan; 73(2):113-20. PubMed ID: 22674214
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PCA3-based nomogram for predicting prostate cancer and high grade cancer on initial transrectal guided biopsy.
    Elshafei A; Chevli KK; Moussa AS; Kara O; Chueh SC; Walter P; Hatem A; Gao T; Jones JS; Duff M
    Prostate; 2015 Dec; 75(16):1951-7. PubMed ID: 26384170
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [New challenges and earlier approved methods in the laboratory diagnosis of prostate cancer].
    Kovács GL
    Magy Onkol; 2014 Dec; 58(4):301-9. PubMed ID: 25517448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A critical appraisal of biomarkers in prostate cancer.
    Narayan VM
    World J Urol; 2020 Mar; 38(3):547-554. PubMed ID: 30993424
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Additional value of PCA3 density to predict initial prostate biopsy outcome.
    Ruffion A; Perrin P; Devonec M; Champetier D; Decaussin M; Paparel P; Vlaeminck-Guillem V
    World J Urol; 2014 Aug; 32(4):917-23. PubMed ID: 24500192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue.
    Stephan C; Jung M; Rabenhorst S; Kilic E; Jung K
    Clin Chem Lab Med; 2015 Jun; 53(7):1109-18. PubMed ID: 25720086
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PCA3 and TMPRSS2-ERG gene fusions as diagnostic biomarkers for prostate cancer.
    Yang Z; Yu L; Wang Z
    Chin J Cancer Res; 2016 Feb; 28(1):65-71. PubMed ID: 27041928
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer.
    Hessels D; Smit FP; Verhaegh GW; Witjes JA; Cornel EB; Schalken JA
    Clin Cancer Res; 2007 Sep; 13(17):5103-8. PubMed ID: 17785564
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prostate cancer marker panel with single cell sensitivity in urine.
    Nickens KP; Ali A; Scoggin T; Tan SH; Ravindranath L; McLeod DG; Dobi A; Tacha D; Sesterhenn IA; Srivastava S; Petrovics G
    Prostate; 2015 Jun; 75(9):969-75. PubMed ID: 25808739
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel Biomarkers for Prostate Cancer Detection and Prognosis.
    Filella X; Foj L
    Adv Exp Med Biol; 2018; 1095():15-39. PubMed ID: 30229547
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel tools to improve patient selection and monitoring on active surveillance for low-risk prostate cancer: a systematic review.
    van den Bergh RC; Ahmed HU; Bangma CH; Cooperberg MR; Villers A; Parker CC
    Eur Urol; 2014 Jun; 65(6):1023-31. PubMed ID: 24491309
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictive value of four kallikrein markers for pathologically insignificant compared with aggressive prostate cancer in radical prostatectomy specimens: results from the European Randomized Study of Screening for Prostate Cancer section Rotterdam.
    Carlsson S; Maschino A; Schröder F; Bangma C; Steyerberg EW; van der Kwast T; van Leenders G; Vickers A; Lilja H; Roobol MJ
    Eur Urol; 2013 Nov; 64(5):693-9. PubMed ID: 23683475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A molecular signature of PCA3 and ERG exosomal RNA from non-DRE urine is predictive of initial prostate biopsy result.
    Donovan MJ; Noerholm M; Bentink S; Belzer S; Skog J; O'Neill V; Cochran JS; Brown GA
    Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):370-5. PubMed ID: 26345389
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.
    Auprich M; Bjartell A; Chun FK; de la Taille A; Freedland SJ; Haese A; Schalken J; Stenzl A; Tombal B; van der Poel H
    Eur Urol; 2011 Nov; 60(5):1045-54. PubMed ID: 21871709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.